{"id":810151,"date":"2022-07-27T19:06:53","date_gmt":"2022-07-27T17:06:53","guid":{"rendered":"https:\/\/15.161.165.86\/non-categorizzato\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/"},"modified":"2022-07-27T19:06:53","modified_gmt":"2022-07-27T17:06:53","slug":"versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/","title":{"rendered":"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies"},"content":{"rendered":"VANCOUVER, British Columbia &amp; SAN FRANCISCO--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant\u2019s portfolio of biologics-focused biotechs. Versant and AbCellera already have enabled three of the firm\u2019s stealth-stage companies under previous partnerships.\n\n\n\nUnder the terms of the deal, Versant portfolio companies will have rights to develop and commercialize the resulting therapeutic antibodies. AbCellera will receive research payments from the companies and will be eligible to receive downstream clinical and commercial milestone payments plus royalties on net sales of products. Further terms are <div class=\"leaky_paywall_message_wrap\"><div id=\"leaky_paywall_message\"><a href=\"https:\/\/bebeez.it\/abbonati\/\">Abbonati<\/a> o <a href=\"https:\/\/bebeez.it\/mio-account\/\">Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia &amp; SAN FRANCISCO&#8211;(BUSINESS WIRE)&#8211;$ABCL&#8211;AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant\u2019s portfolio of biologics-focused biotechs. Versant and AbCellera already have enabled three of the firm\u2019s stealth-stage companies under previous partnerships. Under the terms of the deal, Versant portfolio companies [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-810151","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies - BeBeez\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia &amp; SAN FRANCISCO--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant\u2019s portfolio of biologics-focused biotechs. Versant and AbCellera already have enabled three of the firm\u2019s stealth-stage companies under previous partnerships. Under the terms of the deal, Versant portfolio companies [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-27T17:06:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies\",\"datePublished\":\"2022-07-27T17:06:53+00:00\",\"dateModified\":\"2022-07-27T17:06:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/\"},\"wordCount\":1058,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/\",\"name\":\"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-07-27T17:06:53+00:00\",\"dateModified\":\"2022-07-27T17:06:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/","og_locale":"en_US","og_type":"article","og_title":"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies - BeBeez","og_description":"VANCOUVER, British Columbia &amp; SAN FRANCISCO--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) and Versant Ventures today announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant\u2019s portfolio of biologics-focused biotechs. Versant and AbCellera already have enabled three of the firm\u2019s stealth-stage companies under previous partnerships. Under the terms of the deal, Versant portfolio companies [&hellip;]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/","og_site_name":"BeBeez","article_published_time":"2022-07-27T17:06:53+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/"},"author":{"name":"","@id":""},"headline":"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies","datePublished":"2022-07-27T17:06:53+00:00","dateModified":"2022-07-27T17:06:53+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/"},"wordCount":1058,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/","name":"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-07-27T17:06:53+00:00","dateModified":"2022-07-27T17:06:53+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/versant-ventures-collaborates-with-abcellera-to-accelerate-drug-development-for-its-portfolio-of-biotech-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/810151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=810151"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/810151\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=810151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=810151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=810151"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=810151"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=810151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}